G Buchanan - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

G Buchanan

Showing results (301-310 of 303) with videos related to

Pageof 31

Sort By:

You have reached the last page of results.This site can display upto 303 results.

Molecular Cancer Therapeutics|September 19, 2019

Aurora A-Selective Inhibitor LY3295668 Leads to Dominant Mitotic Arrest, Apoptosis in Cancer Cells, and Shows Potent Preclinical Antitumor EfficacyJian Du, Lei Yan, Raquel Torres, et al.

Nature Communications|May 4, 2026

Characterization of KRASG12C inhibitor olomorasib single-agent and combination with activity in KRASG12C-mutant modelsShengbin Peng, Youyan Zhang, Xi Lin, et al.

Innovation (Cambridge (Mass.))|May 8, 2026

Overlooked considerations in prescribing green and blue infrastructure solutions for urban environmentsPrashant Kumar, Karina Corada Perez, Akash Biswal, et al.

Pageof 31

Search research articles

Showing results (301-310 of 303) with videos related to

Sort By:

Pageof 31

You have reached the last page of results.This site can display upto 303 results.

Molecular Cancer Therapeutics|September 19, 2019

Aurora A-Selective Inhibitor LY3295668 Leads to Dominant Mitotic Arrest, Apoptosis in Cancer Cells, and Shows Potent Preclinical Antitumor EfficacyJian Du, Lei Yan, Raquel Torres, et al.

Nature Communications|May 4, 2026

Characterization of KRASG12C inhibitor olomorasib single-agent and combination with activity in KRASG12C-mutant modelsShengbin Peng, Youyan Zhang, Xi Lin, et al.

Innovation (Cambridge (Mass.))|May 8, 2026

Overlooked considerations in prescribing green and blue infrastructure solutions for urban environmentsPrashant Kumar, Karina Corada Perez, Akash Biswal, et al.

Pageof 31